Angiotensin I-converting enzyme inhibitors (ACEi) cause both chronic and acute side effects, including rare but potentially life-threatening angioedema (AE). The main hypothesis to be tested in this study was that metallopeptidases and kinin receptors are present in oropharyngeal tissues and that their expression is modulated by ACEi and inflammation. Novel realtime polymerase chain reaction analysis was developed and allowed the relative quantification of tissue's gene expression for neprilysin, membrane-bound aminopeptidase P (mAPP), and both B 1 and B 2 kinin receptor subtypes in tongue, parotid gland, and laryngeal tissue (areas especially involved in the gravest clinical forms of AE) and in kidney in a porcine model (single injection or 7-day ACEi oral treatments applied or lipopolysaccharide injected as a positive inflammatory control). The results provide evidence of the expression and activities of kininases in oropharyngeal tissues in the swine. ACEi treatment modulated the expression of neutral endopeptidase and mAPP mRNA, but the corresponding enzyme activities and that of angiotensin I-converting enzyme (ACE) were generally stable in tissues. The 7-day ACEi treatment up-regulated both kinin receptor mRNAs in the oropharynx and the B 1 receptor mRNA in the lingual vascular endothelium (immunohistochemistry). The inhibition of ACE in plasma is responsible for an accumulation of bradykinin and des-arginine 9 -bradykinin generated during activation of the contact system with glass beads. The expression of critical components of the kallikrein-kinin system in the oropharyngeal tissues supports the role of kinins in ACEi-induced AE.
physiological and pathological cardiovascular responses, mainly vasodilatation, increased capillary permeability, and pain processes (Leeb-Lundberg et al., 2005) . Bradykinin and kallidin (Lys-bradykinin) exert their pharmacological activities by binding to their constitutively expressed kinin B 2 receptor before being metabolized by multiple peptidases (Leeb-Lundberg et al., 2005) . The identity of the metallopeptidases involved in bradykinin metabolism in vitro and their relative importance vary according to the biological medium considered. In various cell types and tissues, such as kidney, endothelial cells, and cardiomyocytes, neutral endopeptidase 24.11 (NEP, neprilysin) plays an important role in the degradation of bradykinin (Raut et al., 1999) . In human plasma, bradykinin is metabolized mostly by three metallopeptidases (Decarie et al., 1996; Cyr et al., 2001) . Angiotensin I-converting enzyme (ACE) constitutes the main degradation pathway. Carboxypeptidase N transforms bradykinin and kallidin into their active metabolites, des-arginine 9 -bradykinin (des-Arg 9 -BK) and Lys-des-Arg 9 -BK (des-Arg 10 -kallidin), respectively (a minor metabolic pathway in plasma unless ACE is inhibited). We have also shown that aminopeptidase P (X-prolyl aminopeptidase, APP) plays an important role in the metabolism of kinins in plasma, mostly for des-Arg 9 -BK (Cyr et al., 2001) . Although the carboxytruncated metabolites of bradykinin and kallidin are largely inactive under normal conditions, they are the agonists of the strongly regulated B 1 receptors, of which receptor synthesis is increased in experimental models of inflammation under the control of cytokines, MAP kinases, and specific transcription factors (LeebLundberg et al., 2005) .
We have previously reported a decreased degradation of endogenous des-Arg 9 -BK in the plasma of hypertensive patients who, while treated with an ACEi, experienced an AE . This anomalous breakdown was linked to a decreased aminopeptidase P plasma activity, supporting a pathogenic mechanism relying on kinin catabolism Molinaro et al., 2002) . Human aminopeptidase P exists in both cytosolic and membrane-bound forms, the latter being most likely responsible for plasma activity . Moreover, a recent report describes a single nucleotide polymorphism within the membrane-bound aminopeptidase P (mAPP) gene XPNPEP2 linked to low plasma aminopeptidase P activity (Duan et al., 2005) . Although plasma aminopeptidase P deficiency states could predispose to AE in some ACEi-treated patients, little is known about the physiological roles of this metallopeptidase in tissues. These observations based on plasma can hardly be extrapolated to a localized AE affecting the oropharyngeal tissues.
The first aim of this paper was to quantify metallopeptidases and kinin receptor mRNAs in oropharyngeal tissues in swine using novel real-time PCR analysis. As a second step, we have defined the effect of inflammation and of acute and chronic ACE inhibition on the expression of these biochemical entities that limit and mediate, respectively, the pharmacological activity of kinins during an episode of AE. As a sequel to our preceding in vitro investigations, we have defined the effect of these in vivo treatments on the metabolism of endogenous kinins in plasma.
Materials and Methods
Reagents. The ACEi enalaprilat (Vasotec I.V., 1.25 mg/ml) and enalapril (Vasotec) were from Merck Frosst Canada (Kirkland, QC, Canada); RNAlater was from Ambion (Austin, TX); bradykinin and des-Arg 9 -BK were acquired from Peninsula Laboratories (Belmont, CA); LPS extracted from Escherichia coli serotype O111:B4, L-arginine, and o-phthalaldehyde were from Sigma-Aldrich (Oakville, ON, Canada); and TRIzol reagent was purchased from Invitrogen (Burlington, ON, Canada). The internally quenched fluorescent substrates (Abz)RGL(EDDnp) for NEP (Medeiros et al., 1997) , K(Dnp)P-PGK(Abz) for mAPP , and (Abz)YRK(Dnp)P for ACE (Araujo et al., 2000) were gifts from Prof. A. Carmona (Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de Sã o Paulo, Sã o Paulo, Brazil). PCR primers were synthesized by Biocorp Inc. (Montreal, QC, Canada) .
Animals. Twenty-four healthy male cross-bred barrows (Yorkshire ϫ Landrace) approximately 2 months old and weighing 16.1 Ϯ 1.6 kg were purchased from a specific pathogen-free farm (Faculté de Médecine Vétérinaire, Université de Montréal, Montréal, Canada) and were kept in an isolated room. Within the room, the animals were housed in separate pens. Food and water were provided ad libitum throughout the experiment.
Experimental Protocol. The experimental protocol was approved by the Faculty of Veterinary Medicine ethics committee (Université de Montréal) in accordance to the Canadian Council on Animal Care Guidelines. The 24 animals were randomly allocated in four different treatment groups: 1) the one-time ACEi treatment group (enalaprilat 100 g/kg i.v. injection once), 2) the 7-day ACEi treatment group (enalapril maleate tablet 20 mg p.o.) 12 h apart for 7 consecutive days, 3) the LPS group [5 g/kg dissolved in 1 ml of NaCl (0.9%) i.v. once], and 4) untreated animals (control group). At the end of the experiments, all of the animals were euthanized with an i.v. lethal dose of sodium pentobarbital (540 mg/ml). The one-time ACEi group was euthanized 4 h postenalaprilat i.v. injection, the 7-day ACEi group was euthanized on the morning of the eighth day, and the LPS animals were sacrificed 6 h post-LPS i.v. injection. Sacrifice immediately followed the last blood samplings. Two control pigs were sacrificed with each group of treated animals.
Venous blood samples were collected in 1) the one-time ACEi group before injection, 45 min post-ACEi injection, and 4 h postACEi injection; 2) the 7-day ACEi group on the first (before the first oral dose of ACEi), third, and eighth days of treatment; and 3) the LPS group before and 6 h after LPS injection. Control group samples were taken at all time points on six animals. Blood samples were collected into sodium citrate and EDTA-treated tubes (Vacutainer; BD Biosciences, Franklin Lakes, NJ). The citrated blood samples were immediately centrifuged (2400g for 10 min), and the plasma from each animal was aliquoted in polypropylene tube and immediately stored at Ϫ80°C until further analysis. Tissues from the oropharyngeal zone (parotid gland, tongue, and laryngeal tissue) and a piece of kidney were quickly excised upon euthanasia, washed in ice-cold saline solution, and flash-frozen in liquid nitrogen and/or conserved in RNAlater for protein and RNA extraction.
Assessment of the Systemic Inflammatory Response. C-reactive protein, an indicator of a systemic inflammatory response, was quantified in plasma with a commercial solid-phase sandwich immunoassay kit (PHASE RANGE porcine C-reactive protein assay kit; Tri-Delta Diagnostics, Inc., Morris Plains, NJ) according to the manufacturer's instructions. Total and differential leukocytes counts were routinely obtained with a Coulter counter (Beckman Coulter, Fullerton, CA), and these systemic parameters were complemented by rectal temperature assessment in LPS-treated and control animals.
Biochemical Investigations in Plasma. The activity of ACE, aminopeptidase P, and carboxypeptidase N was measured using the methods described previously. ACE activity was determined by Bü hlmann ACE radioenzymatic assay (ALPCO: American Labora-tory Products Company, Windham, NH) according to the manufacturer's instructions. The activity of aminopeptidase P and carboxypeptidase N was assessed by fluorimetric assay as described previously (Cyr et al., 2001 ). The metabolism of the endogenous kinins, bradykinin and its active metabolite des-Arg 9 -BK, was studied through in vitro plasma contact system activation as described extensively elsewhere (Cyr et al., 2001; Molinaro et al., 2002) , using two specific competitive chemiluminescent enzyme immunoassays, as previously described (Decarie et al., 1994; Raymond et al., 1995) .
Total RNA Isolation from Tissues. Total RNA was isolated using the TRIzol reagent and RNAqueous-4PCR kit (Ambion) according to the manufacturer's instructions with modification. In brief, ϳ50 mg of each tissue was first homogenized in the TRIzol reagent, and chloroform was added. After centrifugation, the aqueous phase was mixed with the lysis/binding solution and the RNAqueous-4PCR protocol was followed subsequently. All RNA samples were finally DNase-treated to remove traces of genomic DNA, quantified using RiboGreen fluorescent nucleic acid stain (RNA quantification kit; Invitrogen, Carlsbad, CA), and stored at Ϫ80°C until use.
Reverse Transcription and Real-Time Polymerase Chain Reaction. The 0.5-g amount of total RNA was transcribed into cDNA using 50 units of Moloney murine leukemia virus reverse transcriptase (Applied Biosystems, Foster City, CA) and 5 M oligo(dT) 16 primer. Quantification of the RNAs was performed by realtime PCR using the LightCycler 2.0 apparatus (Roche Diagnostics, Mannheim, Germany). Two microliters of cDNA were brought to a final volume of 20 l containing 2 mM MgCl 2 , 2 l of LightCyclerFastStart DNA SYBRGreen I Mix (Roche Diagnostics), and 0.5 or 0.7 M primers (Table 1) in water. After initial activation of the DNA polymerase at 95°C for 10 min, the amplification conditions were as follows: 47 cycles consisting of denaturation at 95°C for 15 s, annealing for 12 s at 62°C [glyceraldehydes 3-phosphate dehydrogenase (GAPDH), B 1 receptor, B 2 receptor, and neprilysin] or 15 s at 60°C (mAPP), and extension at 72°C. The extension times were calculated from the amplicon size (base pairs/25). Fluorescence data were acquired at the end of each extension phase. After amplification, a melting curve analysis from 65 to 98°C with a heating rate of 0.1°C/s with a continuous fluorescence acquisition was made. Standard curves were created from specific PCR products. The corresponding real-time PCR efficiency (E) of one cycle in the exponential phase was calculated from the slopes calculated by the LightCycler software according to eq. 1 (Pfaffl, 2001 ).
Quantification was done by using a mathematical model in eq. 2 to determine the relative quantification of a target gene compared with a reference gene. The relative quantification of a target transcript is based on the PCR efficiency of the individual transcripts and crossing point (Cp) deviation (calculated by the second derivative maximum method) of a control and an unknown sample normalized by a reference transcript. This relative expression ratio can be calculated as shown in eq. 2,
where E R is the real-time PCR efficiency of a reference gene transcript, E T is the real-time PCR efficiency of target gene transcript, CpR is the deviation of reference gene transcript, CpT ϭ Cp deviation of the target gene transcript, S is the unknown sample, and C is the calibrator. The expression was normalized against the expression of GAPDH and calculated for each animal for a given tissue and target gene.
Measurement of ACE, mAPP, and Neprilysin Enzymatic Activities in Tissues.
Tissues from the oropharyngeal zone, namely from the parotid gland, tongue, and laryngeal tissue, and a piece of kidney weighing ϳ500 mg were homogenized in Tris buffer [50 mM Tris, 100 mM NaCl, pH 7.4, and 1ϫ Complete protease inhibitor solution (protease inhibitor cocktail tablets; Roche Diagnostics)] with a Polytron homogenizer (Brinkmann Instruments, Rexdale, ON, Canada) and sonicated for 10 min. A solution of CHAPS (Sigma-Aldrich) was added to each homogenate to final concentration of 8 mM, incubated on ice for 2 h, and centrifuged (1750g, 4°C), and the supernatant containing total membrane proteins was collected (Raut et al., 1999) . Final protein concentrations were determined using the bicinchoninic acid method (Pierce Chemical, Rockford, IL).
Metallopeptidase (ACE, mAPP, and neprilysin) activities were measured in tissue extracts using quenched fluorescent substrates. Reactions were run in duplicate in 96-well flat bottom plates (Costar UV plate 3635; Corning Life Sciences, Acton, MA) in a final volume of 150 l. Ten milligrams of membrane protein extracts in a 50 mM Tris-Cl buffer, pH 7.4, 100 mM NaCl, and 10 M ZnCl 2 for ACE and neprilysin or 100 mM Hepes buffer, pH 7.4, for mAPP were incubated with a 10 M final concentration of (Abz)YRK(Dnp)P for ACE, (Abz)RGL(EDDnp) for neprilysin, or K(Dnp)PPGK(Abz) for mAPP. Plates were preincubated at 37°C for 15 min before substrate addition. Fluorescence (excitation wavelength of 340 nm, emission wavelength of 420 nm) was assessed kinetically in a FL600 microplate fluorescence plate reader (BioTek, Winooski, VT). Fluorescent units were converted into picomoles of hydrolyzed substrate based on a standard fluorescence curve.
Immunohistochemistry. Lingual tissue samples from all pigs were obtained at necropsy and fixed using 10% buffered formalin phosphate for histological examination. Paraffin-embedded tissue sections (5-m thick) were prepared, submitted to an antigen-retrieving procedure (Marceau et al., 1999) , and immunostained at 
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at ASPET Journals on April 9, 2017 jpet.aspetjournals.org 37°C for 1.5 h with one of the following antibodies: monoclonal anti-␣-actin (clone 1A4, dilution 1:100; Sigma-Aldrich), monoclonal anti-human-B 2 receptor (Blaukat et al., 2003) , polyclonal anti-von Willebrand factor (vWF, dilution 1:100; DakoCytomation California Inc., Carpinteria, CA), or a mixture of polyclonal antibodies raised against six distinct peptides from the B 1 receptor human sequence (Mazenot et al., 2001 ). The antibody staining was revealed using horseradish peroxidase-coupled goat anti-mouse IgG (dilution 1:100; Sigma-Aldrich) for primary monoclonal antibodies or monoclonal anti-rabbit IgG (dilution 1:200; Sigma-Aldrich) for polyclonal antibodies (30-min reactions, 37°C). The secondary antibodies were allowed to react for 5 to 15 min at 25°C with the Immunopure metal-enhanced diaminobenzidine substrate (Pierce Chemical). Endogenous peroxidase was initially inhibited in tissue sections using 3% H 2 O 2 (5 min).
Statistical Analysis. The systemic inflammatory response and the enzymatic activities in plasma are analyzed using a two-way analysis of variance with repeated measures on one of the factors. The factors are the groups with four levels (one-time ACEi treatment, 7-day ACEi treatment, LPS, and control) and the time with two levels [before experimental protocol (T 0 ) and at sacrifice (T S )], the latter being the repeated factor. In case of interaction, separate analyses of variance with the factor group are performed at each time. Significant differences with the control groups were further assessed using Dunnett's test (p Ͻ 0.05).
For the normalized ratio of the examined target gene/GAPDH generated by the real-time PCR analysis, a logarithmic transformation was used to bring the data closer to normality. The statistical significance was established using the mean values of the log normalized ratio calculated for each animal for a given tissue. The biochemical investigations in tissues are analyzed separately for each tissue. For the log normalized ratio and the biochemical parameters, a one-way analysis of variance with a factor group with four levels (one-time ACEi treatment, 7-day ACEi treatment, LPS, and control) was used followed by Dunnett's test when a significant difference was observed (p Ͻ 0.05).
Results
Assessment of the Systemic Inflammatory Response. Fig. 1A represents the systemic inflammatory status of each group of animals assessed by plasma C-reactive protein concentrations immediately before experimental protocol and prior to sacrifice. There is a significant interaction between the factors time and group for C-reactive protein analysis [F(3,20) ϭ 11.19, p Ͻ 0.001]. No difference was observed between the groups at T 0 [F(3,21) ϭ 1.37, p ϭ 0.279]; however, at T S , a significant difference was shown [F(3,21) ϭ 9.147, p Ͻ 0.001]. The concentration of this acute-phase protein was significantly higher for the LPS group when compared with the control group (p ϭ 0.001). The one-time or 7-day treatment with ACEi does not significantly modify the plasma concentrations of this acute-phase protein marker. Figure 1B shows the number of circulating leukocytes for the four groups before treatment and prior to sacrifice. As for C-reactive protein, a significant interaction was observed between the factors time and group [F(3,19) The LPS injection produced a significantly decreased total leukocyte count at T S compared with the control animals (p Ͻ 0.001). Finally, the rectal temperatures measured in the LPS and control groups showed that the temperature peaked at 4 h and returned to baseline by the T S (6 h) (data not shown).
Biochemical Analysis in Plasma. Enzymatic activities measured in blood plasma for ACE, aminopeptidase P, and carboxypeptidase N are presented in Table 2 . For ACE, the four groups progressed differently and a significant interaction was observed between the factors time and group [F(3,20) No group effect at each time was observed, but a time effect was significant only for LPS group where carboxypeptidase N activity was 67 Ϯ 10 nmol ⅐ min Ϫ1 ⅐ ml Ϫ1 at T 0 and increased to 86 Ϯ 6 nmol ⅐ min Ϫ1 ⅐ ml Ϫ1 at euthanasia (p Ͻ 0.001).
Endogenous Bradykinin and Des-Arg 9 -BK Metabolism. Fig. 2 illustrates the calculated area under the curve (AUC), representing the accumulation and subsequent catabolism of immunoreactive bradykinin and des-Arg 9 -BK measured during the in vitro activation of the contact system using glass beads in 1 ml of plasma sampled from each animal at T S . For bradykinin, a significant interaction was observed between the factors time and group [F(3,20) in fact, the one-time ACEi (p ϭ 0.006) and 7-day ACEi (p Ͻ 0.001) treatment groups were statistically higher from the control group. For the LPS group, the AUC was not statistically different from the control group, neither for bradykinin nor for des-Arg 9 -BK. There were no differences among groups from samples collected at every other time (data not shown).
Real-Time Polymerase Chain Reaction Applied to Tissues. Specificity of PCR products was confirmed on the agarose gel illustrated in Fig. 3A and resulted in single bands, each one with the predicted length. The melting curves analyses are an exact and fast method to check PCR specificity and are displayed as first-negative derivative of the fluorescence versus the temperature. Typical LightCycler melting curve analysis from the amplification of the targets and reference transcripts resulted in product-specific melting temperatures, as illustrated in Fig. 3B . Table 3 shows the log of normalized ratios for metallopeptidases in oropharyngeal tissues and kidney. In Fig. 4 and Table 4 , the same information is given for the kinin receptors. For mAPP, the 7-day ACEi treatment significantly increased the expression of the mRNA corresponding to this enzyme in the tongue (p Ͻ 0.001) and laryngeal tissue (p ϭ 0.027). The expression of neprilysin mRNA was significantly increased in kidney, tongue, and parotid for the 7-day ACEi treatment group (p ϭ 0.038, p ϭ 0.007, and p ϭ 0.026, respectively), but a significant decrease in its expression was observed for the one-time ACEi and LPS treatments in kidney (p Ͻ 0.001). The expression of the B 1 receptor mRNA was significantly higher in kidney and oropharyngeal tissues only for the 7-day treatment with ACEi (kidney, tongue, and parotid, p Ͻ 0.001; laryngeal tissue, p ϭ 0.002; Fig. 4 ). Neither acute ACEi treatment nor single LPS injection significantly affected the expression of the mRNA coding for this receptor in the kidney, tongue, parotid gland, or laryngeal tissue at the tested time points. The one-time ACEi treatment and LPS treatment led to a significantly lower expression of the B 2 receptor mRNA in the kidney (p ϭ 0.002 and p ϭ 0.008, respectively; Table 4 ). In contrast, in the tongue (p ϭ 0.002) and laryngeal tissue (p ϭ 0.007), B 2 receptor mRNA expression was significantly increased by a 7-day treatment with ACEi.
Metallopeptidase Activities in Tissues. Metallopeptidase activities measured in tissue extracts from control animals using quenched fluorescent substrates are given in Ta- 
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at ASPET Journals on April 9, 2017 jpet.aspetjournals.org ble 5. Neither acute nor 7-day ACEi treatments, nor the single LPS injection, significantly affected ACE activities in the kidney, tongue, parotid gland, or laryngeal tissue when compared with the control group (data not shown). However, a significant treatment effect was noted for the neprilysin activity in the kidney and for the mAPP activity in parotid gland [F(3,20) ϭ 19.567, p Ͻ 0.001; and F(3,20) ϭ 3.440, p ϭ 0.036, respectively] when compared with the control group. Indeed, the one-time and 7-day ACEi treatment significantly increased neprilysin activity in the kidney, 20461 Ϯ 841 (p Ͻ 0.001), and mAPP activity in the parotid gland, 294 Ϯ 151 (p ϭ 0.027), respectively.
Immunohistochemistry Applied to Lingual Tissue. The tongue, examined below the epithelial surface, contains connective tissue and striated muscle along with blood vessels of various sizes (Fig. 5, hematoxylin and eosin stain) . The blood vessels are further identified by immunoreactivity for the endothelial cell marker vWF (one-cell thick lines) and by the smooth muscle cell marker ␣-actin (thicker labeling in arteriole and venule walls). Unexpectedly, tissues from all animals treated for 7 days with the ACEi exhibit only faint vWF vascular staining (Fig. 5) . The staining for the B 2 receptor is present in endothelial cells of identifiable blood vessels in all groups, but the comparatively weaker B 1 receptor signal is only found after treatment with LPS or 7-day ACEi.
Discussion
AE is a local inflammatory reaction, yet most if not all previous biochemical investigations on AE are based on plasma analysis (Nussberger et al., 1998 ). Here we have set out to analyze in more detail the pathogenesis of ACEiinduced AE. To this end, we used an animal model (i.e., the pig) that is large enough to allow repeated blood sampling and harvesting of oropharyngeal tissues to support multiple analyses.
Clinical and experimental lines of evidence plead for a multifactorial mechanism of ACEi-associated AE. Angioedema could be the result of a coincidence of distinct pharmacological, metabolic, and pathophysiological factors. Previously, we have shown that AE patients have an anomaly of the metabolism of des-Arg 9 -BK because of a defect of plasma aminopeptidase P activity, evidenced only in the presence of ACEi Molinaro et al., 2002) . We have shown recently that this low aminopeptidase P depends largely on genetic factors (Duan et al., 2005) . Because the incidence of AE is higher in hypertensive smokers treated with an ACEi (Coats, 2002) , we analyzed the effect of inflammation (a pathophysiological factor) on the tissue expression of metallopeptidases and on the plasma metabolism of kinins. Inflammation was mimicked by a sublethal dose of LPS. We chose a dose substantially less than that typically used in rats and mice, because, like human and nonhuman primates, pigs are extremely sensitive to LPS (Warren et al., 1997) . Since AE episodes have been reported as early as on the first day (Wood et al., 1987) or later during ACEi treatment (pharmacological factor) (Hedner et al., 1992; Shionoiri et al., 1996) , two groups of pigs were treated, acutely or chronically. The dosages of a single injection of 100 g/kg enalaprilat i.v. and the per oral application of 20 mg of enalapril twice daily were chosen in preliminary studies, because they both allowed consistent inhibition of plasma ACE activity, as extensive as in our in vitro studies (Cyr et al., 1999; Molinaro et al., 2002) .
Methods previously developed in our laboratory to define the metabolism of endogenous kinins (Decarie et al., 1994; Raymond et al., 1995; Cyr et al., 2001) were applied to the plasma of the experimental animals. A significant in vitro accumulation of kinins (as assessed by the AUC; Fig. 2 ) has been monitored in the one-time and 7-day ACEi treatment groups when compared with controls. Because aminopeptidase P activities in plasma were similar in both ACEi-treated groups, the observed increased bradykinin and des-Arg 9 -BK concentrations are exclusively a consequence of ACE blockade and not of a nonspecific inhibition of the activity of aminopeptidase P by ACEi. These observations are important as Hooper et al. (1992) reported a nonspecific inhibition of purified pig aminopeptidase P by some ACEi.
We provide evidence for the expression of kininases and kinin receptors in the oropharyngeal tissues of swine. For this purpose, we developed the relative quantification of Fig. 3 . Amplification specificity by real-time PCR. Specificity of PCR products for each primer was visualized in 2% agarose gel and resulted in a single band with the predicted length (A). In addition, a PCR product dissociation curve (melting temperature analysis) was performed, which resulted in single product-specific melting temperature (B).
our target gene transcripts XPNPEP2 (membrane aminopeptidase P), MME (neprilysin), BDKRB1 (B 1 receptor), and BDKRB2 (B 2 receptor) in comparison with the reference GAPDH gene transcript. After an analytical validation, a mathematical approach for data analysis was presented to calculate the relative expression of normalized logarithmic ratios.
We show that gene expression of the metallopeptidases neprilysin and mAPP in the oropharyngeal tissues is lower than that measured in the kidney when expressed as a ratio to GAPDH (Table 3 and data not shown), and the enzyme activity measurements fully support this observation. The kidney is a valuable positive expression control that contains all components of the kallikrein-kinin system. A 7-day treatment with an ACEi increased mAPP mRNA expression in the tongue and laryngeal tissue and also increased neprilysin mRNA expression in kidney, tongue, and parotid gland tissues; paradoxically, neprilysin expression was decreased after a single administration of enalaprilat, as well as in LPS-treated animals, and this only in the kidney. As in the control animals, the corresponding enzyme activities were rather stable, with occasional changes that did not match the mRNA variation. Although these observations suggest that other factors jpet.aspetjournals.org regulate the activity of the peptidases, a high variation of the low activities did not reach statistical significance, even when the activities were higher or lower than those measured in the control animals (Table 5 and data not shown). The mechanisms by which ACEi leads to changes in metallopeptidase mRNA expression in the present experimental model remain to be elucidated, although other laboratories have reported that ACEi increase ACE mRNA and activity in cell systems and in some tissues (Chai et al., 1992; King and Oparil, 1992) . We were unable to assess the effect of ACEi on ACE expression itself, because obtaining valid and specific primers for the porcine gene was not possible and attempts to synthesize primers based on homologous mammalian sequences remained unsuccessful. To circumvent these problems, the quantification of enzyme activities in tissue homogenates using highly sensitive and specific internally quenched fluorescent substrates for ACE was done, as well as for neprilysin and mAPP . In fact, the enzyme activities in oropharyngeal tissues could not be measured using traditional endpoint methods . The effects of ACEi treatments on tissue ACE activities contrast with those observed in plasma; no significant difference was seen in ACE catalytic activity in any tissue for any treatment. These results parallel others in this laboratory for rat and human heart, and they could be explained by a washout of the ACEi during the tissue homogenization for membrane preparation (Kinoshita et al., 1993; Blais et al., 1997 Blais et al., , 2000a . Local tissue inflammation in ACEi-treated pigs took the form of a strong up-regulation of the mRNA levels for the kinin B 1 receptor in all oropharyngeal and renal tissues after the 7-day drug treatment only. This contrasts with B 2 receptor regulation modulated in a tissue-specific manner by 7-day ACEi treatment (mRNA up-regulated in the tongue and laryngeal tissue) and in an apparently inconsistent manner with other tissues or treatments. B 1 and B 2 receptor genes are well documented to be differently regulated in vivo (Leeb-Lundberg et al., 2005) . B 1 receptor mRNA was expected to be low in healthy tissues but upregulated during inflammatory conditions. In our hands, LPS administration at a mid-range level that does not overtly stress the animals (Warren et al., 1997) did not substantially alter kinin receptor mRNA expression in any of the tested tissues despite a marked systemic inflammatory reaction (Naess et al., 1989) . The observed increased plasma carboxypeptidase N in the LPS group supports the idea that the synthesis of this protein is increased by inflammation and can be considered to be an acute-phase reactant protein, as previously observed in patients with inflammatory arthritis (Chercuitte et al., 1987) . The lack of B 1 receptor mRNA up-regulation in this experimental group could be explained by the low dose used and short duration of the endogenous cytokine action (as monitored by the febrile reaction). However, the lingual immunohistochemistry study suggests that some endothelial B 1 receptor protein was still present 6 h post-LPS after a hypothetic rise and fall of the corresponding mRNA; this induction reproduces published functional results for this species (Siebeck et al., 1996) . ACEi-induced B 1 receptor expression has been observed in chronically treated rats (Marin-Castano et al., 2002) , although 48-h treatment with enalaprilat did not induce B 1 receptor expression in the healthy rabbit despite an effective ACE blockade that should theoretically potentiate endogenous kinins (Marceau et al., 1999) . A species-and physiological statedependent toxic reaction to ACEi could explain the upregulation of B 1 receptor without overt systemic inflammatory reaction (as C-reactive protein remained low and leukocyte counts were normal in ACEi-treated pigs). Vasopressin or epinephrine administration to human subjects depletes endothelial vWF in biopsies from the oral mucosa (Takeuchi et al., 1988) . Such depletion was observed in the lingual vasculature in the 7-day ACEi group and may result from a slow onset hemodynamic adaptation that includes the secretion of these hormones and a form of endothelial stimulation that favors B 1 receptor expression.
In conclusion, here we provide a sensitive real-time PCR analyses that permit gene expression of metallopeptidases and kinin receptors in the oropharyngeal tissues in the pig. We have detected subtle changes after ACEi treatment. The low activity of kininases, the presence of specific receptors, mainly B 1 receptor, and the modulatory effect of inflammation and ACEi support a plausible mechanism whereby kinins could initiate a vasogenic inflammatory process (AE) via the sustained stimulation of either or both kinin receptor subtypes. These results obtained using ACEi could be the basis of future investigations on the pathophysiology of AE associated with more "modern" cardiovascular drugs; e.g., AT1 receptor antagonists and vasopeptidase inhibitors. Moreover, encouraging results in the clinical trial of the B 2 receptor antagonist Icatibant support that kinin receptor blockade is of therapeutic interest in hereditary AE (Rosenkranz et al., 2004) . It remains to be seen whether B 1 receptor blockade could be more effective in this and other forms of AE. 
